Bio Nebraska Members Included in Collaboration to Evaluate Cancer Early Detection Technology
Bio Nebraska members Grail, Amgen, and Bristol Myers Squibb are included in a collaboration to evaluate cancer early detection technology for minimal residual disease. Read more